Microbot Medical (MBOT) announced the publication of an article in the Journal of Vascular and Interventional Radiology, titled “In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study.” “We are very pleased by the publication of the ACCESS-PVI results in JVIR, a leading voice in the field. This is a recognition that speaks to the quality and impact of the study,” said Juan Diaz-Cartelle, chief medical officer. “We would like to thank all the co-authors and we are looking forward to generating more clinical evidence that would foster appreciation for the benefits of the LIBERTY system.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical Highlights Pivotal LIBERTY Study Publication Milestone
- Microbot Medical Highlights LIBERTY Commercial Traction at Roth Conference
- Microbot Medical Highlights LIBERTY Progress at Oppenheimer Conference
- Microbot Medical Highlights LIBERTY Robotics Amid Radiation Safety Focus
- Microbot ‘commends’ AMA for efforts to protect workers from ionizing radiation
